Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by CancerSlayer


V.TLT

RE:RE:Antiviral deal coming?

Donein25 wrote: Did anyone see the J&J news today; they dropped a Phase 3...

October 8, 2024

V.TLT

RE:Complete Response Rate at 450 Days 28.6% ?

Eoganacht wrote: In the news release it says the 450 day CR rate is 26.5...

October 8, 2024

V.TLT

RE:RE:Swimmers Plot

enriquesuave wrote: Great news!  Data still pending at distant time...

October 7, 2024

V.TLT

RE:RE:RE:RE:Delays part of the FDA process...

Longholder99 wrote: Other than delays caused by a worldwide pandemic (2yr...

October 1, 2024

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:This is it...

O12009 wrote: I believe your right in a lot of what you are saying but on the...

September 28, 2024

V.TLT

RE:RE:RE:RE:RE:RE:RE:News After The Close

Mikee3003 wrote: Don't kid yourself Tapps, if big pharma were drooling...

September 25, 2024

V.TLT

Thanks Wildbird

The FDA's recent approval history for BCG-unresponsive NMIBC (i.e...

September 22, 2024

V.TLT

RE:RE:Help for aging monkeys?

Addendum to last post: Ruthenium compounds as a potential Diabetes Type 2...

September 18, 2024

V.TLT

RE:Help for aging monkeys?

Perhaps aging monkeys could also benefit from ruthenium-based compounds...

September 18, 2024

V.TLT

RE:Ruvidar will be the go to drug when we get to trials.

O12009 wrote: An antibody-drug conjugate developed by Daiichi Sankyo and...

September 17, 2024

V.TLT

RE:RE:Hey Roger and management!

Oilminerdeluxe wrote: I had abrief exchange with someone recently, who should...

September 16, 2024

V.TLT

RE:More Than $7 With Combined Indications

Bigkahuna57 wrote: @2b7f6fab & DX33, et al.  You both make great...

September 15, 2024

V.TLT

RE:RE:RE:RE:Me not smart...

Yep...and based on all of the data/research performed to date re: ruthenium...

September 12, 2024

C.COOL

RE:RE:RE:RE:Suspension

Fortunately, I've been out of this dog for a while, but is Core's...

September 12, 2024

V.TLT

RE:Me not smart...

thadeush wrote: but this latest news about the herpes virus is incredible. It...

September 11, 2024

V.TLT

RE:Merck loses ground to Summit

Longholder99 wrote: Competition in the lung cancer arena has Summit...

September 9, 2024

C.COOL

RE:Re:Suspension

Cool was doomed to fail...fortunately for many investors, they exited after...

September 8, 2024

V.TLT

RE:RE:RE:RE:RE:RE:RE:General question for the board

Imagine the reality of being cancer-free after one TLT treatment.  ...

September 5, 2024

V.TLT

RE:RE:RE:RE:RE:RE:General question for the board

Glad you brought that valid point up... CG0070 requires treatments spanning...

September 5, 2024

V.TLT

RE:RE:RE:RE:RE:New Proactive Video

Chicken pox is also a member of the Herpes Virus family & hence shares...

September 4, 2024

Featured Company